{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:43:17Z","timestamp":1790390597478,"version":"4.1.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Autoantibodies are hallmark findings in systemic sclerosis (SSc), often present prior to disease onset. Clinical diagnosis and prognosis of SSc have long relied on the antitopoisomerase \u2013 anticentromere \u2013 anti-RNA polymerase antibody trichotomy. However, many more autoantibodies found in SSc are being actively investigated for insights into triggering events, mechanisms of tolerance break, and connections to tissue damage. This review examines recent studies on SSc autoantibodies and the early events that lead to their development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Recent work has elucidated potential connections between human cytomegalovirus infection, silicone breast implants, and malignancy to SSc autoantibody development. At the level of the dendritic cell:T cell interaction, where tolerance is broken, new studies identified shared motifs in the peptide-binding domains of SSc-associated human leukocyte antigen alleles. Immunological analysis of SSc patient B cells has uncovered several anomalies in the regulatory capacities of SSc na\u00efve and memory B cell populations. Expanding efforts to uncover new SSc autoantibodies revealed anti-CXCL4, anticollagen V, and other autoantibodies as potential players in disease pathogenesis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Further research into the role of autoantibodies in SSc development may uncover new mechanism-guided therapeutic targets. In addition, a better understanding of autoantibody associations with SSc disease outcomes will improve clinical care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000834","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T20:01:37Z","timestamp":1631304097000},"page":"486-494","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Insights into origins and specificities of autoantibodies in systemic sclerosis"],"prefix":"10.1097","volume":"33","author":[{"given":"Eleni","family":"Tiniakou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Darrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"e0214202","DOI":"10.1371\/journal.pone.0214202","article-title":"Autoantibodies are present before the clinical diagnosis of systemic sclerosis","volume":"14","author":"Burbelo","year":"2019","journal-title":"PLoS One"},{"key":"R3-20250526","first-page":"3","article-title":"Role of viral infections in the etiopathogenesis of systemic sclerosis","volume":"31","author":"Moroncini","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1529-0131(199902)42:2<389::AID-ANR23>3.0.CO;2-P","article-title":"Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis","volume":"42","author":"Neidhart","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/08916930410001710046","article-title":"IgG antibodies to human cytomegalovirus late protein UL94 in patients with systemic sclerosis","volume":"37","author":"Namboodiri","year":"2004","journal-title":"Autoimmunity"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.clim.2019.07.012","article-title":"A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosis","volume":"207","author":"Efthymiou","year":"2019","journal-title":"Clin Immunol"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00296-020-04643-z","article-title":"A study of antigen-specific anticytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies","volume":"40","author":"Gkoutzourelas","year":"2020","journal-title":"Rheumatol Int"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12026-020-09124-w","article-title":"Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosis","volume":"68","author":"Efthymiou","year":"2020","journal-title":"Immunol Res"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1073\/pnas.1906593116","article-title":"HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry","volume":"117","author":"Gourh","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"R10-20250526","first-page":"387","article-title":"Diffuse sclerodermia: its frequency; its occurrence in stone-masons; its treatment by fibrolysin\u2014elevations of temperature due to fibrolysin injections","volume":"12","author":"Bramwell","year":"1914","journal-title":"Edinb Med J"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10067-016-3533-1","article-title":"Occupational and environmental scleroderma. Systematic review and meta-analysis","volume":"36","author":"Rubio-Rivas","year":"2017","journal-title":"Clin Rheumatol"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1093\/rheumatology\/keaa446","article-title":"Occupational silica exposure in an Australian systemic sclerosis cohort","volume":"59","author":"Patel","year":"2020","journal-title":"Rheumatology"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2147\/OARRR.S262428","article-title":"Association of silicone breast implants, breast cancer and anti-RNA polymerase III autoantibodies in systemic sclerosis: case-based review","volume":"12","author":"De Angelis","year":"2020","journal-title":"Open Access Rheumatol"},{"issue":"(Suppl 131)","key":"R14-20250526","doi-asserted-by":"crossref","first-page":"25","DOI":"10.55563\/clinexprheumatol\/mg0paj","article-title":"Association of anti-RNA polymerase III antibody with silicone breast implants rupture in a multicentre series of Italian patients with systemic sclerosis","volume":"39","author":"Lazzaroni","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.autrev.2016.01.001","article-title":"Smoke and autoimmunity: the fire behind the disease","volume":"15","author":"Perricone","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1203475420957950","article-title":"Toward understanding of environmental risk factors in systemic sclerosis [Formula: see text]","volume":"25","author":"Ouchene","year":"2021","journal-title":"J Cutan Med Surg"},{"key":"R17-20250526","first-page":"25","article-title":"Smoking and systemic sclerosis: influence on microangiopathy and expression of antitopoisomerase I antibodies in a monocentric cohort","volume":"38 Suppl 125","author":"Ciaffi","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"909","DOI":"10.5114\/ada.2020.102107","article-title":"Clinical consequences of the presence of anti-RNA Pol III antibodies in systemic sclerosis","volume":"37","author":"Wielosz","year":"2020","journal-title":"Postepy Dermatol Alergol"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.40893","article-title":"Protective effect against cancer of antibodies to the large subunits of both RNA polymerases I and III in scleroderma","volume":"71","author":"Shah","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.41493","article-title":"Cancer in systemic sclerosis: analysis of antibodies against components of the Th\/To complex","volume":"73","author":"Mecoli","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fmed.2020.00165","article-title":"Antinuclear antibodies with a homogeneous and speckled immunofluorescence pattern are associated with lack of cancer while those with a nucleolar pattern with the presence of cancer","volume":"7","author":"Gauderon","year":"2020","journal-title":"Front Med"},{"key":"R23-20250526","first-page":"71","article-title":"Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease","volume":"35 Suppl 106","author":"Shah","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cei.13417","article-title":"Novel insights into dendritic cells in the pathogenesis of systemic sclerosis","volume":"201","author":"Carvalheiro","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/08916934.2016.1230848","article-title":"Topoisomerase I peptide-loaded dendritic cells induce autoantibody response as well as skin and lung fibrosis","volume":"49","author":"Mehta","year":"2016","journal-title":"Autoimmunity"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/art.41248","article-title":"Definition of naturally processed peptides reveals convergent presentation of autoantigenic topoisomerase-I epitopes in scleroderma","volume":"72","author":"Tiniakou","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41598-018-37038-z","article-title":"Interactions of HLA-DR and topoisomerase I epitope modulated genetic risk for systemic sclerosis","volume":"9","author":"Kongkaew","year":"2019","journal-title":"Sci Rep"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.humimm.2016.05.012","article-title":"Negatively-charged amino acids at the peptide-binding pocket of HLA-DPB1 alleles are associated with susceptibility to antitopoisomerase I-positive systemic sclerosis","volume":"77","author":"Lee","year":"2016","journal-title":"Hum Immunol"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00005-008-0014-5","article-title":"The role of B lymphocytes as antigen-presenting cells","volume":"56","author":"Chen","year":"2008","journal-title":"Arch Immunol Ther Exp"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.3390\/ijms20246152","article-title":"Toll-like receptor mediated activation of natural autoantibody producing B cell subpopulations in an autoimmune disease model","volume":"20","author":"Erd\u0151-Bony\u00e1r","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.3390\/ijms22062877","article-title":"Analysis of PI3K pathway associated molecules reveals dysregulated innate and adaptive functions of B cells in early diffuse cutaneous systemic sclerosis","volume":"22","author":"Simon","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1346-8138.2009.00762.x","article-title":"Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis","volume":"37","author":"Hamaguchi","year":"2010","journal-title":"J Dermatol"},{"key":"R34-20250526","first-page":"1784","article-title":"Autoantibodies to a novel Rpp38\u200a(Th\/To) derived B-cell epitope are specific for systemic sclerosis and associate with a distinct clinical phenotype","volume":"58","author":"Koenig","year":"2019","journal-title":"Rheumatology"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.revmed.2019.12.020","article-title":"Characteristics of Systemic Sclerosis patients with positive anti-Th\/To antibodies: About 6 patients and literature review","volume":"41","author":"Muller","year":"2020","journal-title":"Rev Med Interne"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s10067-020-05479-5","article-title":"Antivinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc cohorts","volume":"40","author":"Suliman","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13075-020-2128-z","article-title":"Detecting gastrointestinal manifestations in patients with systemic sclerosis using antigAChR antibodies","volume":"22","author":"Nakane","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/s41467-019-09683-z","article-title":"CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-\u03b1 production in systemic sclerosis","volume":"10","author":"Lande","year":"2019","journal-title":"Nat Commun"},{"key":"R40-20250526","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145102","article-title":"Anti-CXCL4 antibody reactivity is present in systemic sclerosis (SSc) and correlates with the SSc type I interferon signature","volume":"21","author":"Lande","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/antib10020012","article-title":"New autoantibody specificities in systemic sclerosis and very early systemic sclerosis","volume":"10","author":"Lande","year":"2021","journal-title":"Antibodies"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13075-018-1545-8","article-title":"Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis","volume":"20","author":"Weigold","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fimmu.2018.00428","article-title":"Autoantibodies in serum of systemic scleroderma patients: peptide-based epitope mapping indicates increased binding to cytoplasmic domains of CXCR3","volume":"9","author":"Recke","year":"2018","journal-title":"Front Immunol"},{"key":"R44-20250526","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13075-019-2052-2","article-title":"Proposition of a novel animal model of systemic sclerosis induced by type V collagen in C57BL\/6 mice that reproduces fibrosis, vasculopathy and autoimmunity","volume":"21","author":"Teodoro","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"R45-20250526","doi-asserted-by":"crossref","first-page":"604602","DOI":"10.3389\/fimmu.2020.604602","article-title":"Identification of autoimmunity to peptides of collagen V \u03b11 chain as newly biomarkers of early stage of systemic sclerosis","volume":"11","author":"Velosa","year":"2020","journal-title":"Front Immunol"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s42358-019-0063-y","article-title":"Anticollagen type v: a marker of early systemic sclerosis?","volume":"59","author":"Ugolini-Lopes","year":"2019","journal-title":"Adv Rheumatol"},{"key":"R47-20250526","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/acr.23763","article-title":"Anti-RNPC-3\u200a(U11\/U12) antibodies in systemic sclerosis in patients with moderate-to-severe gastrointestinal dysmotility","volume":"71","author":"McMahan","year":"2019","journal-title":"Arthritis Care Res"},{"key":"R48-20250526","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keab279","article-title":"Anti-RNPC-3 antibody predicts poor prognosis in patients with Interstitial Lung Disease associated to Systemic Sclerosis","author":"Callejas-Moraga","year":"2021","journal-title":"Rheumatology"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s42358-020-00140-w","article-title":"Antiannexin V autoantibodies and vascular abnormalities in systemic sclerosis: a longitudinal study","volume":"60","author":"Horimoto","year":"2020","journal-title":"Adv Rheumatol"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/bjd.17886","article-title":"Anti-C1q autoantibodies are frequently detected in patients with systemic sclerosis associated with pulmonary fibrosis","volume":"181","author":"Liaskos","year":"2019","journal-title":"Br J Dermatol"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/RHU.0000000000000759","article-title":"ASCA (Anti-Saccharomyces cerevisiae Antibody) in patients with scleroderma","volume":"25","author":"Fedrigo","year":"2019","journal-title":"J Clin Rheumatol"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"100049","DOI":"10.1016\/j.jtauto.2020.100049","article-title":"Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: the case of antieIF2B antibodies","volume":"3","author":"Ceribelli","year":"2020","journal-title":"J Transl Autoimmun"},{"key":"R53-20250526","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1536\/ihj.19-659","article-title":"Characteristics of pulmonary arterial hypertension in patients with systemic sclerosis and anticentriole autoantibodies","volume":"61","author":"Maki","year":"2020","journal-title":"Int Heart J"},{"key":"R54-20250526","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/03009742.2019.1641615","article-title":"Immunoglobulin G galactosylation levels are decreased in systemic sclerosis patients and differ according to disease subclassification","volume":"49","author":"Liu","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"R55-20250526","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/iid3.270","article-title":"Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: A preliminary study","volume":"7","author":"Klemm","year":"2019","journal-title":"Immun Inflamm Dis"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13075-019-1839-5","article-title":"Significance of antineutrophil cytoplasmic antibodies in systemic sclerosis","volume":"21","author":"Moxey","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"R57-20250526","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/08916934.2021.1916915","article-title":"The prevalence and role of functional autoantibodies to angiotensin-converting-enzyme-2 in patients with systemic sclerosis","volume":"54","author":"Mizio\u0142ek","year":"2021","journal-title":"Autoimmunity"},{"key":"R58-20250526","first-page":"115","article-title":"Fingerprinting of antialpha enolase antibodies in systemic sclerosis","volume":"38 Suppl 125","author":"Perconti","year":"2020","journal-title":"Clin Exp Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T22:00:44Z","timestamp":1748296844000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000834","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]}}}